Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:57 PM
Ignite Modification Date:
2025-12-24 @ 3:57 PM
NCT ID:
NCT07164092
Eligibility Criteria:
Inclusion Criteria:
* Myopia of at least -1.0 D in both eyes, astigmatism of less than 2.0 D, anisometropia of objective spherical equivalent ≤ 1.50 D.
* Documented myopic progression of at least 0.5 D in the past one year.
Exclusion Criteria:
* Children with ocular or systemic diseases that potentially influence myopia or refractive power.
* Ocular diseases, e.g., cataracts, glaucoma
* Posterior segment hereditary and acquired pathological disorders.
* History of any previous ocular surgery.
* History of any ocular injuries.
* Previous use of interventions (such as atropine, pirenzepine, orthokeratology lens, or other optical methods) for myopia control
* Allergy to atropine, cyclopentolate or benzalkonium chloride
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Years
Maximum Age:
18 Years
Study:
NCT07164092
Study Brief:
Protocol Section:
NCT07164092